COMT and irritable bowel syndrome: In our previous large RCT (n = 262), testing components of placebo effects in IBS [31], we found that the number of methionine alleles in the catechol-O-methyltransferase (COMT) val158met polymorphism was associated with placebo response, especially when placebo was combined with a supportive patient-provider relationship [32].